Latest reports of Phase II trials of BL-8040 from Israel’s Bioline Rx (see Nov newsletter), show that 38% of patients with acute myeloid leukemia, went into complete remission after just two cycles of the treatment.  All these patients had previously failed to recover from other leukemia treatments.

http://www.globes.co.il/en/article-biolinerx-reports-positive-phase-ii-leukemia-drug-results-1001113425